The primary virulence factor of Vibrio cholerae, cholera toxin (CT), initiates a pathway in epithelial cells that leads to the severe diarrhoea characteristic of cholera. Secreted CT binds to GM1 on the surface of host cells to facilitate internalisation. Many bacterial toxins, including CT, have been shown to be additionally delivered via outer membrane vesicles (OMVs). A fraction of the closely related heat labile toxin produced by enterotoxigenic Escherichia coli has been demonstrated to reside on the surface of OMVs, where it binds GM1 to facilitate OMV internalisation by host cells. In this work, we investigated whether OMV-associated CT is likewise trafficked to host cells in a GM1-dependent mechanism. We demonstrated that a majority of CT is secreted in its OMVassociated form and is located exclusively inside the vesicle. Therefore, the toxin is unable to bind GM1 on the host cell surface, and the OMVs are trafficked to the host cells in a GM1-independent mechanism. These findings point to a secondary, noncompeting mechanism for secretion and delivery of CT, beyond its well-studied secretion via a Type II secretion system and underscore the importance of focusing future studies on understanding this GM1-independent delivery mechanism to fully understand Vibrio cholerae pathogenesis.
| INTRODUCTION
The Gram-negative bacterium, Vibrio cholerae, is the causative agent of cholera, a severe diarrhoeal infection transmitted through the ingestion of contaminated food or water (Reidl & Klose, 2002) . Because of the organism's highly virulent nature, severe outbreaks are common.
Most recently, an ongoing outbreak in Yemen has affected at least 300,000 people, with an increasing death toll of around 1,700 patients (Balakrishnan, 2017) , and more than 7-year-long outbreak in Haiti has killed over 10,000 people (Ivers, 2017) .
Along with toxin-coregulated pilus, cholera toxin (CT) is one of the primary virulence factors produced by pathogenic strains of V. cholerae (Faruque, Albert, & Mekalanos, 1998; Matson, Withey, & DiRita, 2007) . CT is a member of the AB class of bacterial toxins with a heterodimeric A subunit (CTA1/CTA2) and a homo-pentameric B subunit (CTB5) (Beddoe, Paton, Le Nours, Rossjohn, & Paton, 2010; Sanchez & Holmgren, 2011) . CT is secreted through a two-step, Type II secretion (T2S) system (Sandkvist, 2001a (Sandkvist, , 2001b Sandkvist et al., 1997; Sikora, 2013) . In the first step, the A and B subunits are translocated across the inner (cytoplasmic) membrane, in a Secdependent process. Once in the periplasmic space, the subunits are assembled into the holotoxin through the formation of disulfide bonds, catalysed by the TcpG disulfide oxidoreductase. Finally, the extracellular protein secretion apparatus recognises the B5 pentamer of the assembled holotoxin to facilitate secretion across the outer membrane (OM; Peek & Taylor, 1992; Sikora, 2013; Yu, Webb, & Hirst, 1992) . After secretion, the B5 subunit of the CT holotoxin recognises and binds to the GM1 ganglioside receptor on the surface of small intestinal epithelial cells, triggering endocytosis of the GM1-CT complex. The toxin is then transported to the endoplasmic reticulum, where the enzymatic fragment of the A subunit dissociates from the holotoxin and unfolds (Taylor, Banerjee, Ray, Tatulian, & Teter, 2011) before retro-translocating to the cytosol where it activates adenylate cyclase. This activation results in an increase in cytosolic cAMP, which in turn leads to diarrhoea by means of an excessive release of water and chloride into the intestinal lumen (Chinnapen, Chinnapen, Saslowsky, & Lencer, 2007; Lencer, Delp, Neutra, & Madara, 1992; Lencer, Hirst, & Holmes, 1999; Spangler, 1992; Wernick, Chinnapen, Cho, & Lencer, 2010) .
Like other Gram-negative bacteria, V. cholerae produces outer membrane vesicles (OMVs) (Elluri et al., 2014; Mondal et al., 2016) , and a recent study has demonstrated that physiologically active CT is found in association with these vesicles (Chatterjee & Chaudhuri, 2011) . OMVs are naturally released spherical buds of the OM with an enveloped periplasmic content. These vesicles carry a selective cargo, either associated with their membrane bilayer or encapsulated within their lumen, including DNA, RNA, proteins, lipids, and lipopolysaccharide (LPS). OMVs secreted from Gramnegative pathogens have been proposed to act as vehicles for delivering active toxins and other virulence factors to distant host cells (Bonnington & Kuehn, 2014; Kulp & Kuehn, 2010; Schwechheimer & Kuehn, 2015) .
OMVs use a variety of mechanisms to enter the host cells and deliver their cargo (Kaparakis-Liaskos & Ferrero, 2015; O'Donoghue & Krachler, 2016) . Cholesterol-rich lipid rafts have been commonly reported to be involved in the uptake of OMVs produced by a number of species, including enterotoxigenic Escherichia coli (ETEC), Haemophilus influenzae, Campylobacter jejuni, and Pseudomonas aeruginosa, among others (Bomberger et al., 2009; Elmi et al., 2012; Kaparakis et al., 2010; Kesty, Mason, Reedy, Miller, & Kuehn, 2004; Mondal et al., 2016; Sharpe, Kuehn, & Mason, 2011) , whereas OMVs produced by other organisms, including
Helicobacter pylori and enterohemorrhagic E. coli, have been reported to enter cells in cholesterol-independent endocytic processes (Bielaszewska et al., 2013; Bielaszewska et al., 2017; Canas et al., 2016; Kunsmann et al., 2015; Parker, Chitcholtan, Hampton, & Keenan, 2010) .
The role of OMV-associated toxins in the trafficking and internalisation of OMVs likewise seems to vary by organism. Delivery of some OMVs occurs through a toxin-receptor-independent mechanism (Bielaszewska et al., 2013; Elluri et al., 2014; Kunsmann et al., 2015) ; however, the uptake of ETEC OMVs has been reported to be facilitated by the interaction of vesicle-associated heat-labile enterotoxin (LT) with its GM1 ganglioside receptor . LT is closely related to CT in both structure and biological activity, including its secretion through a T2S pathway and recognition of GM1 on the host cell (Tauschek, Gorrell, Strugnell, & Robins-Browne, 2002) . We hypothesized that due to similarity between LT and CT, vesicle-associated CT might also act as a targeting moiety for OMVs, triggering host cell entry of the OMVs through binding to the toxin's cellular receptor, GM1. It has been proposed that the affinity of LT for LPS, found on the outer surface of the OMVs, regulates the cellular uptake of ETEC OMVs by allowing LT-receptor (GM1) binding (Horstman & Kuehn, 2002) . Therefore, in the present work, we conducted a series of experiments to characterise the location of CT in V. cholerae 569B OMVs and to determine the role of GM1 in the interaction of the OMVs with host cells.
| RESULTS

| Isolation and characterisation of V. cholerae OMVs
We first investigated the secretion of OMVs by CT-expressing V. cholerae strain 569B. The culture was grown in nutrient broth until the late logarithmic phase to avoid contamination of the OMVs with lysed cell debris, and the OMVs were purified from the cell-free supernatants. Scanning electron microscopy images of the OMVs exhibited spherical vesicles with diameters ranging from 60 to 250 nm ( Figure 1a ). Dynamic light scattering was used to determine that the average diameter of the 569B OMVs was 198.5 nm with a polydispersity of 0.292.
To determine whether CT is associated with 569B OMVs, Western blot analysis was performed using a polyclonal anti-CT antibody.
Two strong antibody-reactive bands were found, with molecular weights of approximately 29 and 18 kDa, confirming that the toxin is associated with the OMVs (Figure 1b) . We then used a dot blot analysis ( Figure S1 ) to determine what fraction of the protein in the OMV is CT (mass CT/total protein mass). Purified 569B OMVs were spotted onto a nitrocellulose membrane along with a serial dilution of CT with known mass. The blot was then incubated with an anti-CT polyclonal antibody, and the intensity of the OMV dots was compared with the intensity of the CT dots to calculate the mass of CT in the OMVs.
The total protein concentration of the OMVs was measured by collecting the absorbance at a wavelength of 280 nm (A 280 ) on a Nanodrop ™ spectrophotometer. This allowed us to calculate that CT composed 0.5% of the total protein content of the vesicles.
To measure the fraction of secreted CT in the supernatant that is associated with OMVs, both isolated OMVs and the OMV-free supernatant were spotted on nitrocellulose along with purified CT in a serial dilution ( Figure 1c) . We found that, by mass, 75% of the secreted CT is The mass of CT present in purified OMVs or the OMV-free supernatant was determined by comparing the intensity of an antibody-reactive spot with that of CT standards with known mass. OMVs = outer membrane vesicles associated with vesicles, whereas only 25% of the secreted CT is in a free, soluble form.
| OMVs induce morphological changes in host cells
To verify that the OMVs are biologically active, we tested 569B OMV-mediated cytotoxicity. A previous study has shown that CT treatment of FHs 74 intestinal epithelial cells induces a dosedependent morphological change from an elongated (spindly) to a rounded form (Jin et al., 2013) . We found that the 569B OMVs induced a similar effect on cells in a dose-dependent manner (Figure 2a ), demonstrating the biological activity of the OMVs. The cell morphology was scored on a scale of 1 (spindly) to 4 (round); quantification of the images in Figure 2a is shown in Figure 2b .
To compare the cytotoxicity of purified OMVs with the OMV-free supernatant, cells were treated with the same volume of OMVs and OMV-free supernatant, and the resulting cell rounding was quantified.
As shown in Figure 2c , the OMV fraction induced a greater cellular response than the supernatant. Representative images used for quantification in Figure 2c are presented in Figure S2 .
| CT does not have affinity for V. cholerae O1 LPS
The related toxin, LT, has been shown to reside partially on the surface of ETEC OMVs due to its affinity for LPS, which composes the outer leaflet of the OMV (Horstman & Kuehn, 2002) . We therefore sought to investigate the affinity of CT for the lipids comprising the OMV, using two lipid dot blot analyses. In the first blot, we investigated the affinity of CT for the OMV lipids, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (POPG), tetraoleoyl cardiolipin (TOCL), and LPS, along with GM1. The affinity of CT for GM1 has previously been measured to be 4.6 × 10 −12 by surface plasmon resonance (Kuziemko, Stroh, & Stevens, 1996) and 5.2 × 10 −8 by isothermal titration calorimetry (Masserini, Freire, Palestini, Calappi, & Tettamanti, 1992) . In our dot blot containing GM1 (Figure 3a , i), we likewise observed a strong affinity of CT for GM1, and only a slight affinity for POPE and TOCL; no affinity for 569B LPS or POPG was detected. This result demonstrates that any affinity of CT for OMV lipids is significantly weaker than the toxin's affinity for GM1.
In a second dot blot, we investigated the affinity of CT for only the OMV lipids, POPE, POPG, TOCL, and LPS; no GM1 was included in this blot so that we could compare the affinity of CT specifically . One-way analysis of variance followed by Bonferroni's post hoc test was used to compare differences between treated and untreated samples; *p < .05, **p < .01, and ***p < .001. (c) Quantification of 569B OMV and OMV-free supernatant-mediated cytotoxicity. Cells were treated with purified OMVs or OMV-free supernatant. Control cells were treated with Hank's balanced salt solution. OMV-mediated alterations in cell morphology were scored on a scale of 1 (spindly) to 4 (rounded). Data are expressed as mean ± SD (N = 3). The level of significance was determined between cells treated with OMVs and OMV-free supernatant using an unpaired two-tailed t test. ***p < .001. OMVs = outer membrane vesicles; CT = cholera toxin for OMV lipids. In the absence of GM1, we observed some affinity of CT for POPE, very slight affinity for POPG and TOCL, and no affinity for 569B LPS ( Figure 3a ). These results demonstrate that although CT has some affinity for the OMV lipid, POPE, this affinity is significantly weaker than the toxin's known strong affinity for GM1.
Phosphatidylethanolamine lipids compose a majority of the inner leaflet of the OM and likely that of the OMV as well, whereas LPS is located exclusively in the outer leaflet of the OM and OMV. Thus, this result suggests that, unlike LT, the association of CT with OMVs is not driven by an affinity for the outer surface of the vesicle. The LPS structure of the purified 569B LPS was verified by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis ( Figure 3b ).
| CT is located within the lumen of OMVs
To determine the location of CT relative to the OMVs, a proteinase K susceptibility assay was carried out in the absence or presence of the membrane disrupting agent, SDS. As shown in Figure 
| Association of OMVs with host cells is not GM1-dependent
The intravesicular location of CT suggests that the toxin would be unable to bind to its GM1 receptor on host cells. To determine if this so, a GM1 ELISA was performed using a serial dilution of CT as a standard. GM1 was coated on the plate, and either soluble CT or purified 569B OMVs were added in varying amounts. As expected, soluble CT bound strongly to coated GM1, and preincubation of the toxin with GM1 inhibited this binding (Figure 5a) . Surprisingly, neither untreated nor GM1-pretreated OMVs exhibited any binding to the FIGURE 3 Characterisation of soluble CT association with OMV lipids. (a) Lipid dot blot analysis of CT affinity for (i) POPE, POPG, TOCL, 569B LPS, and GM1 and (ii) POPE, POPG, TOCL, and 569B LPS (with no GM1). In the presence of GM1, free CT was found to have strong affinity for GM1, and in absence of GM1, it had some affinity for POPE. In both cases, no affinity for 569B LPS was seen. (b) SDS-PAGE analysis of purified LPS from V. cholerae 569B. Lane 1 is the LPS standard and Lane 2 is 569B LPS. OMVs = outer membrane vesicles; CT = cholera toxin; LPS = lipopolysaccharide We first investigated the localization of CT in the OMVs, hypothesizing that the toxin must be located on the surface of the OMVs to mediate OMV binding to GM1. However, unlike LT, we found that CT has no affinity for LPS, which composes the outer surface of the OMV, and is located entirely within the lumen of the vesicles. We then demonstrated that the host cell association of CT-containing 569B
OMVs occurs through a mechanism that is independent of the GM1-
This finding is in contradiction with a previous report about OMVs produced by a different strain of V. cholerae, O395, (Chatterjee & Chaudhuri, 2011) , in which they found that soluble GM1 inhibits OMV-mediated cAMP production and cytotoxicity, although they did not directly measure binding of the OMVs to GM1. This difference may be due to strain-to-strain variations in CT secretion, OMV production, and/or LPS structure. Although both strains belong to the O1 The dispensability of toxins for cellular uptake of OMVs has been observed in other studies. Enterohemorrhagic E. coli hemolysin,
V. cholerae cytolysin, and cytolethal distending toxin expressed by
Aggregatibacter actinomycetemcomitans and Campylobacter jejuni are a few examples of other OMV-associated virulence factors that are delivered to the host cell through a toxin-independent mechanism (Bielaszewska et al., 2013; Elluri et al., 2014; Elmi et al., 2012; Lindmark et al., 2009; Rompikuntal et al., 2012) . Notably, Shiga toxin (Stx2a), the key virulence factor responsible for cytotoxicity of OMVs released from E. coli O104:H4, is another AB5 toxin, which, like CT, is located within the lumen of the OMV, thus protected from enzymatic degradation and inaccessible to its globotriaosylceramide (Gb3) receptor (Kunsmann et al., 2015) . On the other hand, as previously mentioned, LT, also an AB5 toxin, is found on the surface of ETEC OMVs and regulates OMV binding to the GM1 receptor (Horstman & Kuehn, 2002; . However, an extravesicular localization does not necessarily indicate that the toxin is involved in the cellular uptake of OMVs. For example, the leukotoxin (LtxA) produced by
Aggregatibacter actinomycetemcomitans, although enriched in the outer surface of OMVs (Kato, Kowashi, & Demuth, 2002) , is not required for vesicle delivery (Demuth, James, Kowashi, & Kato, 2003) .
The lack of affinity of free CT for LPS and its absence on the outer 
| Strains and culturing conditions
The CT-expressing V. cholerae strain 569B (O1 biotype classical serotype Inaba, ATCC ® 25870 ™ ) was used in this study. The culture was grown in nutrient broth at 37°C with aeration.
Human fetal small intestinal FHs 74 Int cells (ATCC
were cultured in Hybri-care medium (ATCC 46-X ™ ), supplemented with 30 ng/ml epidermal growth factor (EGF, Sigma-Aldrich ® ) and 10% fetal bovine serum (Sigma-Aldrich ® ) at 37°C, with 5% CO 2 . The medium was changed every 2 to 3 days.
| Vesicle purification
OMVs were isolated from V. cholerae as described previously (Schild, Nelson, & Camilli, 2008) , with some modifications. Briefly, after reaching the late logarithmic phase (OD 600 of 1.0), the culture was centrifuged (10,000× g, 10 min, 4°C), and the supernatants were filter-sterilised through a 0.45-μm pore size filter. The supernatant 
| Dynamic light scattering
The size of the OMVs was measured by dynamic light scattering using an ALV/CGS-3 goniometer system. A CONTIN analysis was used to determine the radius. The average diameter (z-average) and size distribution (polydispersity index) of the OMVs were calculated by the cumulants method at 25°C with a laser at a wavelength of 632.8 nm under a scattering angle of 90°.
| Western blot analysis
To characterise the presence of CT in the vesicles, 569B OMV proteins were separated by SDS-PAGE on an 8-16% mini-protean TGX precast protein gel (BioRad). Subsequently, the proteins were electrotransferred to a nitrocellulose membrane for 30 min at 30 V.
The membrane was immersed in blocking buffer (5% non-fat dry milk in Tris-buffered saline with Tween 20 (TBST)), and then incubated with primary antibody (rabbit anti-CT: polyclonal, 1:5000, Abcam) followed by a secondary antibody (goat anti-rabbit immunoglobulin G conjugated to horseradish peroxidase, 1:5000, Southern Biotech). The CT bands were detected using SuperSignal ™ enhanced chemiluminescent substrate (Thermo Fisher Scientific ™ ).
| Calculation of CT concentration in 569B OMVs
A dot blot assay was performed to estimate the CT concentration of the purified 569B OMVs. Two microliters of purified CT (Sigma-Aldrich ® ) in serial dilutions of known concentrations was spotted onto a nitrocellulose membrane. Purified OMVs were then spotted onto the membrane, and the membrane was dried under nitrogen. After incubation with blocking buffer, the OMV-associated CT was detected using the primary and secondary antibodies. A standard curve was plotted for the purified CT spots with known concentration and was used to calculate the concentration of CT in the OMVs. The fractional protein composition of the OMVs (CT/total protein) was then determined by calculating the absorbance at 280 nm (A 280 ) expected for this CT concentration and dividing by the measured A 280 of the OMVs.
A dot blot assay was also performed to measure the percentage of OMV-associated CT in the total CT in the culture. The bacteria-free
Schematic of proposed mechanism of CT association with 569B OMVs. Our results demonstrate that CT has no affinity for LPS, which composes the outer leaflet of the OM and resides entirely within the lumen of the OMVs. We therefore hypothesize that during T2S, some CT remains in the periplasm, allowing it to become incorporated in the OMV lumen. Unlike soluble CT, OMV-associated CT does not bind to the GM1 receptor in the lipid rafts of the host cell membrane because of the toxin's location within the OMV. We propose that CT secretion via OMVs and through the T2S system are therefore complementary mechanisms for CT delivery. OMVs = outer membrane vesicles; CT = cholera toxin filtered supernatant was concentrated about 20-fold using a polyethersulfone (PES) 10 kDa ultrafiltration centrifugal unit (Pierce; Thermo Fisher Scientific) to avoid losing any CT. The supernatant was then ultracentrifuged (140,000× g, 3 hr, 4°C) using a Beckman SW 55 Ti rotor. The OMV-free supernatant was collected, and the OMV pellet was resuspended in same volume of PBS for further analysis. The samples were concentrated 10-fold using a SpeedVac concentrator (Savant), then 2 μl of each sample was spotted on a membrane containing a serial dilution of CT as standard. CT was then detected using a polyclonal anti-CT antibody.
| Cytotoxicity assays
The OMV-mediated changes in cell morphology were measured using a cell morphology scoring assay (Massol, Larsen, Fujinaga, Lencer, & Kirchhausen, 2004) . 
| LPS purification
LPS was purified from V. cholerae 569B using the hot phenol-water extraction method as described before (Westphal, 1965) with some modifications. The cells were centrifuged, and the bacterial pellet was washed twice in PBS. After resuspension in hot water, the sample was boiled for 15 min and then cooled to room temperature. The sample was treated with DNase and RNase (37°C, 1 hr) followed by proteinase K (60°C, overnight). Tris-saturated phenol was added to the solution (65°C, 15 min), which was then was cooled on ice and centrifuged (16,000× g, 15 min, 4°C), before the LPS-containing aqueous phase was collected. The phenol phase was incubated again with water (65°C, 15 min), centrifuged again (16,000× g,15 min, 4°C), and the water phase was recovered. The two collected water phases were pooled and dialyzed against deionized (DI) water and subsequently lyophilized.
After separation by SDS-PAGE on an 8-16% polyacrylamide gel, the LPS samples were stained using the Pro-Q Emerald 300 Lipopolysaccharide Gel Stain Kit (Molecular Probes), according to the manufacturer's instructions.
| Lipid dot blot assay
Two lipid dot blot analyses were performed, as described previously (Munnik & Wierzchowiecka, 2013) . On the first nitrocellulose membrane, 2 μg of POPE, POPG, TOCL, and purified 569B LPS were spotted, and on the second membrane, 2 μg of the aforementioned lipids along with GM1 were spotted. Both membranes were then dried with nitrogen gas. The membranes were immersed in blocking buffer (5% non-fat dry milk in Tris-buffered saline (TBS)) for 1 hr and then incubated with CT (0.8 μg/ml in blocking buffer) for 1 hr at room temperature. After three washes with TBS, the membranes were incubated with the primary and secondary antibodies, as described above.
| Proteinase K susceptibility assay
The proteinase K digestion assay was performed as previously described (Balsalobre et al., 2006; Cheng & Schneewind, 2000) . Briefly, OMVs were treated with proteinase K (1 mg/ml, 30 min, 37°C) either in the absence or presence of 1% SDS. Subsequently, the samples were analysed by SDS-PAGE and western blotting using a polyclonal anti-CT antibody.
| Indirect noncompetitive ELISA
The location of the CT on the vesicles was determined using an indirect noncompetitive ELISA. Vesicles were treated with 0.1 M EDTA for 2 hr at 37°C to disrupt the membrane. A microtiter ELISA plate 
| GM1 ELISA
The GM1 ELISA assay was performed as described previously (Horstman & Kuehn, 2000) . Each well of a Maxisorp 96-well microtiter ELISA plate (Nunc) was coated with 100 μl of GM1 ganglioside (1.5 μg/ml in PBS; Sigma-Aldrich ® , St. Louis, MO) overnight at room temperature. After three washes with PBS, the nonspecific binding sites were blocked by addition of 200 μl of 3% (w/v) fatty acid-free BSA. Following three washes, 100 μl of serially diluted samples of either CT, CT preincubated with GM1, 569B OMVs, or 569B OMVs preincubated with GM1 were added to the wells in triplicate and incubated for 2 hr at room temperature with gentle shaking. In each sample, the CT concentration ranged from 80 ng per well to 10 ng per well. In the GM1-treated wells, the CT:GM1 mass ratio was 4:1. The remaining wells were incubated with BSA and served as background control. After three washes with PBS, the plate was incubated with primary and secondary antibody, and the ELISA was developed using TMB solution, as described above.
| Fluorescent labelling of vesicles
The 569B vesicles were fluorescently labelled with FITC (SigmaAldrich ® ), according to the manufacturer's instructions Sharpe et al., 2011) . The purified vesicles were pelleted (140,000× g, 3 hr) and resuspended in 0.1 M sodium bicarbonate at pH 9. The samples were incubated with FITC and stirred for 1 hr at 25°C on a rotator. The free dye was removed from the labelled vesicles by washing twice with PBS (140,000× g, 3 hr). 
| Confocal microscopy
| Statistical analysis
Data are presented as mean ± standard deviation with the indicated sample size. Statistical analysis was performed using an unpaired two-tailed Student's t test or one-way analysis of variance, followed by the post hoc Bonferroni test for multiple comparisons; p values less than .05 were considered statistically significant.
